Buscar
Mostrando ítems 1-10 de 66
JAK2 V617F Mutation Prevalence in Myeloproliferative Neoplasms in Pernambuco, Brazil
(Mary Ann Liebert IncNew RochelleEUA, 2012)
Jak2 46/1 Haplotype Is Associated With Jak2 V617f-positive Myeloproliferative Neoplasms In Brazilian Patients
(WILEY-BLACKWELLHOBOKEN, 2015)
A mutação JAK2 V617F e as síndromes mieloproliferativasJAK2 V617F mutation and the myeloproliferative disorders
(Associação Brasileira de Hematologia e Hemoterapia e daSociedade Brasileira de Transplante de Medula Óssea, 2008)
Estudo da frequência dos haplótipos do gene JAK2 em pacientes portadores de neoplasias mieloproliferativas crônicasEvaluation of the JAK2 gene haplotype frequency in patients with chronic myeloproliferative neoplasm
(Universidade Estadual de MaringáBrasilDepartamento de Análises Clínicas e BiomedicinaPrograma de Pós-Graduação em Biociências Aplicadas à FarmáciaUEMMaringá, PRCentro de Ciências da Saúde, 2018)
JAK2V617F mutation prevalence on chilean adults suffering from primary mesenteric and portal venous thromboses
(Wiley, 2020)
Introduction Mesenteric and portal venous thromboses are rare diseases with high mortality rates and are strongly associated with hepatic cirrhosis, and abdominal inflammatory or tumoral processes, but in some cases can ...
SF3B1, a splicing factor is frequently mutated in refractory anemia with ring sideroblasts
(Nature Publishing GroupLondon, 2012)
CALR, JAK2 and MPL mutation status in Argentinean patients with BCR-ABL1- negative myeloproliferative neoplasms
(Taylor & Francis, 2018-04)
Objectives: To establish the frequency of JAK2, MPL and CALR mutations in Argentinean patients with BCR-ABL1-negative myeloproliferative neoplasms (MPN) and to compare their clinical and haematological features. Methods: ...